Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000227755 refers to the MAD1 mitotic arrest deficient-like 1 pseudogene, a *pseudogene* related to the MAD1L1 gene. Unlike MAD1L1, which encodes a core component of the mitotic spindle assembly checkpoint and plays essential roles in mitosis and tumor suppression, this pseudogene does not encode a functional protein. As such, it is not considered a therapeutic target and has no known direct biological function or disease association[6]. Key distinction: The *functional protein-coding gene* is MAD1L1 (mitotic arrest deficient 1-like 1), an important cell cycle regulator involved in spindle checkpoint control. *ENSG00000227755* is a related pseudogene and does not produce a functional protein product, nor is it itself targeted pharmacologically[6]. If you are interested in the functional target (the protein), refer to *MAD1L1* (Ensembl ID: ENSG00000002822)[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAD1 mitotic arrest deficient-like 1 pseudogene.